Q4 2024 · 13F-HR
Altium Capital Management LLCholdings as filed
Filed 2025-02-13 · accession 0001420506-25-000357
$352.6M
Reported value
67
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 000899104 | ADMA | ADMA BIOLOGICS INC | $23.9M | 6.79% | 1,395,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $18.3M | 5.18% | 432,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $15.4M | 4.38% | 127,000 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $15.4M | 4.38% | 1,850,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $14.1M | 3.99% | 305,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $13.8M | 3.92% | 300,000 | CALL | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $13.0M | 3.68% | 300,000 | CALL | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $12.2M | 3.46% | 165,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $11.3M | 3.20% | 288,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $11.2M | 3.19% | 250,000 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $9.9M | 2.79% | 714,000 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $9.8M | 2.78% | 285,000 | Common | SOLE |
| 589889104 | MMSI | MERIT MED SYS INC | $9.7M | 2.74% | 100,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $9.3M | 2.65% | 250,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $9.1M | 2.58% | 132,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $8.3M | 2.35% | 1,694,000 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $7.6M | 2.14% | 685,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $6.3M | 1.78% | 75,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $6.2M | 1.74% | 10,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $6.0M | 1.70% | 40,000 | Common | SOLE |
| 761152107 | RMD | RESMED INC | $5.9M | 1.69% | 26,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.9M | 1.67% | 146,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $5.6M | 1.59% | 100,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $5.5M | 1.57% | 815,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $5.4M | 1.53% | 1,424,400 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $5.3M | 1.51% | 255,000 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $4.9M | 1.39% | 334,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $4.9M | 1.39% | 370,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $4.8M | 1.37% | 1,579,000 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $4.8M | 1.35% | 452,475 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $4.5M | 1.29% | 385,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $4.3M | 1.23% | 230,257 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $4.1M | 1.17% | 737,000 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MED CORP | $3.6M | 1.03% | 485,000 | Common | SOLE |
| 98420P308 | XTNT | XTANT MED HLDGS INC | $3.3M | 0.93% | 7,415,413 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $3.2M | 0.91% | 1,139,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $2.9M | 0.81% | 355,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.9M | 0.81% | 95,000 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $2.8M | 0.79% | 3,000,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.8M | 0.79% | 175,000 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $2.7M | 0.77% | 206,200 | PUT | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $2.7M | 0.77% | 1,060,000 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $2.7M | 0.76% | 405,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.6M | 0.75% | 475,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $2.6M | 0.74% | 60,000 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $2.6M | 0.73% | 1,428,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $2.4M | 0.69% | 264,562 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $2.0M | 0.55% | 505,000 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $1.9M | 0.53% | 218,386 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $1.6M | 0.46% | 275,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.5M | 0.43% | 396,000 | CALL | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $1.5M | 0.43% | 575,000 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $1.3M | 0.37% | 2,028,534 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $1.2M | 0.33% | 1,473,000 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $936,200 | 0.27% | 310,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $564,928 | 0.16% | 40,352 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $551,046 | 0.16% | 581,395 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $525,516 | 0.15% | 111,812 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $500,462 | 0.14% | 740,000 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $481,516 | 0.14% | 467,491 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $368,480 | 0.10% | 9,400 | CALL | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $294,195 | 0.08% | 92,224 | Common | SOLE |
| 08771Y402 | SRXH | BETTER CHOICE CO INC | $278,379 | 0.08% | 118,459 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $242,636 | 0.07% | 18,326 | Common | SOLE |
| 74907L300 | — | QUOIN PHARMACEUTICALS LTD | $183,659 | 0.05% | 282,249 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $64,285 | 0.02% | 215,000 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $48,033 | 0.01% | 56,100 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.